ADD CONDITION

items per page

Serynth Eczema Relief

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Hydrocortisone 1 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
July 15, 2025
Active ingredient
Hydrocortisone 1 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
July 15, 2025
Manufacturer
Jiangxi Hemei Pharmaceutical Co. , Ltd
Registration number
M017
NDC root
84010-152

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed to temporarily relieve itching and discomfort caused by minor skin irritations, rashes, and inflammation, including those associated with eczema (a condition that makes your skin red and itchy). It works by soothing the affected area, helping you feel more comfortable.

While it can be effective for these common skin issues, it's important to consult with a doctor for any other uses to ensure safety and proper guidance.

Uses

This product is designed to temporarily relieve itching and discomfort caused by minor skin irritations, rashes, and inflammation, including those associated with eczema. If you are considering using this product for other purposes, it’s important to consult with your doctor first to ensure it’s safe and appropriate for your situation.

Dosage and Administration

If you or your child is 2 years old or older, you can apply the medication to the affected area up to 3 to 4 times a day. Make sure to follow this guideline to ensure the best results. However, if your child is under 2 years of age, it’s important to consult a doctor before using the medication. They can provide the best advice tailored to your child's needs.

What to Avoid

It's important to use this medication safely. Do not use it for treating diaper rash; instead, consult your doctor for appropriate advice. If your condition worsens, if symptoms last longer than 7 days, or if they clear up and then return within a few days, stop using the product and speak with your doctor before trying any other hydrocortisone products.

While using this medication, be careful to avoid contact with your eyes, and do not exceed the recommended dosage unless your doctor advises you to do so. Remember, misuse or overuse can lead to dependence (a condition where your body relies on the medication) and other complications. Always prioritize your health and safety by following these guidelines.

Side Effects

This product is for external use only. If your condition worsens, or if your symptoms last more than 7 days or improve and then return within a few days, you should stop using it and consult your doctor. It's important not to start any other hydrocortisone product without first discussing it with your healthcare provider.

Warnings and Precautions

This product is intended for external use only. If you accidentally swallow it, seek medical help or contact a Poison Control Center immediately. It is important to note that this product should not be used to treat diaper rash; please consult your doctor for appropriate treatment options.

You should stop using this product if your condition worsens, if symptoms last longer than 7 days, or if your symptoms improve and then return within a few days. Additionally, do not start using any other hydrocortisone product without first consulting your doctor.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the effects of an overdose for this medication, you should be aware of general signs that may indicate a problem. These can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms or if you believe you have taken too much of the medication, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get checked out if you have concerns about an overdose.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be cautious with any medications, including SERYNTH ECZEMA RELIEF (hydrocortisone 1% eczema relief cream). Currently, there is no specific information available about the safety, dosage adjustments, or special precautions for using this cream during pregnancy.

Before using this product, it’s best to consult with your healthcare provider to discuss any potential risks and to ensure that you are making the safest choice for you and your baby.

Lactation Use

If you are breastfeeding and considering using SERYNTH ECZEMA RELIEF (hydrocortisone 1% eczema relief cream), it's important to note that the drug insert does not provide specific information about its use during nursing. This means there is no clear guidance on how this cream may affect you or your baby while you are breastfeeding.

As always, it's best to consult with your healthcare provider before using any medication, including topical treatments like this one, to ensure it is safe for you and your nursing infant.

Pediatric Use

If your child is under 2 years old, it's important to consult a doctor before using this medication. For children aged 2 years and older, you can apply the medication to the affected area, but be sure not to exceed 3 to 4 applications in a day. Always follow these guidelines to ensure your child's safety and well-being.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. This is particularly true if your kidneys are not functioning as well as they should be. Regular monitoring of your kidney function tests is essential to ensure your safety and the effectiveness of your treatment.

If your creatinine clearance (a measure of how well your kidneys filter waste) is less than 30 mL/min, you should consider taking a lower dose of your medication. Always discuss any concerns or changes in your kidney health with your healthcare provider to ensure you receive the best care possible.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with the medication. However, always ensure that your healthcare provider is aware of all the medications you are using, as this helps them provide the best care tailored to your needs.

By discussing your full medical history and any other treatments, you can help prevent potential issues and ensure your safety.

Storage and Handling

When using this product, it's important to remember that the contents are filled by weight, not volume. This means that the amount you receive may look different than what you might expect based on volume measurements.

To ensure safety and effectiveness, always store the product in a cool, dry place, away from direct sunlight. Handle it carefully to avoid any damage, and follow any specific disposal instructions provided to maintain safety. By following these guidelines, you can help ensure the product remains effective and safe for use.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years and older. If the patient is under 2 years old, it's important to consult a doctor before use.

FAQ

What is the primary use of this drug?

This drug temporarily relieves itching and discomfort associated with minor skin irritations, rashes, inflammation, and eczema.

How should I apply this drug?

Adults and children 2 years of age and older should apply it to the affected area not more than 3 to 4 times daily. For children under 2 years of age, you should ask a doctor.

Are there any warnings I should be aware of?

This product is for external use only. Avoid contact with eyes and do not use more than directed unless advised by a doctor.

What should I do if my condition worsens?

Stop use if your condition worsens, symptoms persist for more than 7 days, or if symptoms clear up and occur again within a few days. Consult a doctor before using any other hydrocortisone product.

Can I use this drug for diaper rash?

No, do not use this product for the treatment of diaper rash. Consult a doctor instead.

What should I do if I accidentally swallow this drug?

If swallowed, get medical help or contact a Poison Control Center right away.

Is there any specific information regarding use during pregnancy or nursing?

The provided text does not include specific information regarding the use of this drug during pregnancy or nursing.

Are there any special considerations for patients with renal impairment?

Yes, dosage adjustments may be necessary for patients with reduced renal function, and renal function tests should be monitored regularly.

Packaging Info

Below are the non-prescription pack sizes of Serynth Eczema Relief (hydrocortisone 1% eczema relief). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Serynth Eczema Relief.
Details

Drug Information (PDF)

This file contains official product information for Serynth Eczema Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of itching and discomfort associated with minor skin irritations, rashes, and inflammation, including those due to eczema.

Limitations of Use Other uses of this product should only be undertaken under the advice and supervision of a healthcare professional.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is consistent and adheres to the specified frequency to achieve optimal results.

For children under 2 years of age, it is advised to consult a physician prior to use. This precaution is necessary to ensure safety and appropriateness of treatment for this age group.

Contraindications

The product is contraindicated for the treatment of diaper rash; consultation with a healthcare professional is advised in such cases.

Discontinue use if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear and then recur within a few days. Do not initiate the use of any other hydrocortisone product without consulting a doctor.

During use, avoid contact with the eyes and do not exceed the recommended dosage unless directed by a healthcare professional.

Warnings and Precautions

For external use only. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

This product is not intended for the treatment of diaper rash. Healthcare professionals are advised to consult a physician for appropriate management in such cases.

Patients should discontinue use if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. It is imperative that patients refrain from initiating the use of any other hydrocortisone product without prior consultation with a healthcare provider.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event that the condition worsens or symptoms persist for more than 7 days, patients are advised to discontinue use and consult a healthcare professional. Additionally, if symptoms clear up and then recur within a few days, patients should also seek medical advice before resuming use of any other hydrocortisone product.

It is important for patients to monitor their condition closely and to seek guidance from a doctor if they experience any of the aforementioned issues.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Serynth Eczema Relief (hydrocortisone 1% eczema relief). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Serynth Eczema Relief.
Details

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information available regarding the use of SERYNTH ECZEMA RELIEF (hydrocortisone 1% eczema relief cream) during pregnancy. As such, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for its use in this population. Healthcare professionals should weigh the potential benefits against any unknown risks when considering the use of this product in pregnant women. It is advisable to consult with a healthcare provider for individualized recommendations.

Lactation

There is no specific information regarding the use of SERYNTH ECZEMA RELIEF (hydrocortisone 1% eczema relief cream) in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment may require dosage adjustments due to reduced renal function. It is essential to monitor renal function tests regularly in individuals with known kidney problems. For patients with a creatinine clearance of less than 30 mL/min, a reduced dose should be considered to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement standard supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities to enhance the understanding of the substance's safety profile and to contribute to the body of knowledge regarding its management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that this product is intended for the treatment of diaper rash and that they should consult a doctor for appropriate guidance.

Patients should be made aware that if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, they should refrain from using any other hydrocortisone product unless directed by a healthcare professional.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes while using this product. Patients should be instructed not to exceed the recommended dosage unless specifically advised to do so by their doctor.

Storage and Handling

The product is supplied in configurations that are filled by weight rather than volume. It is essential to ensure that the contents are handled appropriately to maintain their integrity. Specific storage conditions and handling requirements should be adhered to, although detailed temperature ranges and container specifications are not provided in the current data. Proper handling practices should be followed to ensure the product remains within its specified quality parameters.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, it is advised to consult a doctor before use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Serynth Eczema Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Serynth Eczema Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.